A Multicenter Clinical Study of the Sonablate®450 for the TreAtment of Locally Recurrent Prostate Cancer With HIFU (STAR Trial)

NAUnknownINTERVENTIONAL
Enrollment

117

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2021

Conditions
Recurrent Prostate Cancer
Interventions
DEVICE

High Intensity Focused Ultrasound

High Intensity Focused Ultrasound

Trial Locations (16)

10016

New York University School of Medicine, New York

19004

Urologic Consultants of SE PA, LLP, Bala-Cynwyd

19111

Fox Chase Cancer Center, Philadelphia

20307

Walter Reed National Military Medical Center (Military Personnel Only), Washington D.C.

34102

Specialists in Urology, P.A., Naples

44106

University Hospitals of Cleveland Case Medical Center, Cleveland

45206

University of Cincinnati, Cincinnati

46202

Indiana University, Indianapolis

47130

Metropolitan Urology, PSC, Jeffersonville

53792

University of Wisconsin Comprehensive Cancer Center, Madison

70112

Tulane University, New Orleans

77030

University of Texas M.D. Anderson Cancer Center, Houston

90048

Tower Urology, Los Angeles

90095

David Geffen School of Medicine at University of California Los Angeles, Los Angeles

N6A 4G5

London Health Sciences Centre, London

M6A 3B5

CAN-AM, Toronto

Sponsors

Lead Sponsor

All Listed Sponsors
lead

SonaCare Medical

INDUSTRY